July 31, 2008 2:00 PM
- Text
Exercise In A Pill?
- Adele's Grammy Comeback After Vocal Cord Surgery
- Treating Sleep Apnea in Kids Improves Behavior, Quality of Life
- Chemo May Not Harm Unborn Baby
- C-Sections Not Always Best for Small Babies
- CDC: Doctors Increasingly Prescribe Exercise
- Osteoporosis Medication Linked to Unusual Thigh Fractures
- More from WebMD »
Men using exercise bikes, 6-16-06 (AP (file))
(WebMD)
It may be possible to make a pill that captures the endurance-boosting effects of exercise, scientists report in Cell.
So far, they've tested two compounds in lab tests in mice. One of those compounds, called GW1516, boosted endurance in mice that exercised, but not in sedentary mice. The other compound, called AICAR, improved endurance in mice that didn't exercise at all.
Those compounds haven't yet been tested in people, and they're not on the market. But the researchers are already working on a drug test to screen for traces of GW1516 and AICAR in athletes' blood and urine.
Here's a quick look at the two compounds.
Back in 2004, the researchers -- who included professor Ronald M. Evans, PhD, of the Salk Institute for Biological Studies and the Howard Hughes Medical Institute in La Jolla, Calif. -- reported that they boosted endurance in mice by tweaking a mouse gene to boost the activity of a protein called PPAR-delta.
Evans' team then worked on getting the same result without genetic engineering. They squirted GW1516, which boosts PPAR-delta, into mice's mouths every day for a month.
At the end of the month, the mice ran 68% longer and 70% farther than when the experiment began -- but only if they had been running on exercise wheels daily while taking the drug. GW1516 didn't do anything for mice that weren't exercising.
Next, the scientists focused on another protein called AMPK. They gave sedentary mice a daily injection of AICAR, which boosts AMPK, for a month.
At the end of the month, those mice ran 23% longer and 44% farther than before starting AICAR treatment. That is, their endurance had improved without working out.
The results show that AMPK and PPAR-delta "can be targeted by orally active drugs to enhance training or even to increase endurance without exercise," write the researchers.
The mouse tests were all about skeletal muscles and endurance, not about the drugs' safety or ability to mimic the many other benefits of exercise, such as improving cardiovascular health and making some types of cancer less likely.
By Miranda Hitti
Reviewed by Louise Chang
©2005-2008 WebMD, LLC. All rights reserved
So far, they've tested two compounds in lab tests in mice. One of those compounds, called GW1516, boosted endurance in mice that exercised, but not in sedentary mice. The other compound, called AICAR, improved endurance in mice that didn't exercise at all.
Those compounds haven't yet been tested in people, and they're not on the market. But the researchers are already working on a drug test to screen for traces of GW1516 and AICAR in athletes' blood and urine.
Here's a quick look at the two compounds.
Back in 2004, the researchers -- who included professor Ronald M. Evans, PhD, of the Salk Institute for Biological Studies and the Howard Hughes Medical Institute in La Jolla, Calif. -- reported that they boosted endurance in mice by tweaking a mouse gene to boost the activity of a protein called PPAR-delta.
Evans' team then worked on getting the same result without genetic engineering. They squirted GW1516, which boosts PPAR-delta, into mice's mouths every day for a month.
At the end of the month, the mice ran 68% longer and 70% farther than when the experiment began -- but only if they had been running on exercise wheels daily while taking the drug. GW1516 didn't do anything for mice that weren't exercising.
Next, the scientists focused on another protein called AMPK. They gave sedentary mice a daily injection of AICAR, which boosts AMPK, for a month.
At the end of the month, those mice ran 23% longer and 44% farther than before starting AICAR treatment. That is, their endurance had improved without working out.
The results show that AMPK and PPAR-delta "can be targeted by orally active drugs to enhance training or even to increase endurance without exercise," write the researchers.
The mouse tests were all about skeletal muscles and endurance, not about the drugs' safety or ability to mimic the many other benefits of exercise, such as improving cardiovascular health and making some types of cancer less likely.
By Miranda Hitti
Reviewed by Louise Chang
©2005-2008 WebMD, LLC. All rights reserved
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- Marijuana-smoking motorists twice as likely to crash
- 4.5 million Americans over 50 have artificial knees
- Skin cancer self-exam: What to look for (PHOTOS)
- Norovirus outbreak hits Rider University in N.J
- Things You Didn't Know About Your Penis
- America's pets also have an obesity epidemic
- John Dye Dies: What Killed "Angel" Star?
- PICTURES: 15 Shocking Sexual Fetishes
- America's sodium problem: Not from salty snacks?
- Caffeine inhalers - the next club drug?
- Let's Move! campaign turns 2 today: Is it working?
- Chinese mom gives birth to 15-pound baby
- Woman spotlights uterus didelphys on talk show
- Christina Hendricks: Too Big for Hollywood?
- 8 Tips For Losing Weight After Pregnancy
- HealthPop: Online dating and jaw engraving
Latest CBS News Headlines
on Facebook
on CBS News
- Houston remembered at Clive Davis gala
- Dudley leads Suns past Kings 98-84
- Faces of protest are as varied as Russia itself
- Mystery disease kills thousands in Central America
on Facebook
- Adele sings a cappella for Anderson Cooper
- Occupy protestors kicked out of CPAC
- CPAC: Will Sarah Palin spring a surprise?
- Beyonce and Jay-Z post first photos of Blue Ivy Carter
on CBS News






